Join PER® September 15th for the New York Advanced Practice Collaborative Meeting! Directed toward NP/PAs, this meeting blends presentations on cutting-edge information with panel discussions to enhance learning.

General Discussions

An Interesting Collaboration

By Lisa Schulmeister, RN, MN, APRN-BC, OCN, FAAN
PatientsLikeMe® ( is a patient-centered organization that helps its 350,000 members connect with one another. The website also offers a mechanism where patients can enter and track their medical data, and the organization has used some of this data in its research studies. The data that is generated is considered “real world” data since it is self-reported by the patients.

On June 15, 2015, the FDA announced that it had signed a research collaboration agreement with PatientsLikeMe to determine how patient-reported data can give new insights into drug safety. Both organizations recognize that clinical trial data represents only the experiences of the patients enrolled in the trials; whereas post-approval drug surveillance data are more expansive and more representative of the general population.

The PatientsLikeMe organization recognized the FDA’s action to evaluate newer sources of data to help identify drug risks and benefits, and note the reporting landscape is now changing from healthcare professionals reporting post-approval drug effects to engaging patients to directly report these effects.

Start a discussion
You must log in to use this feature, please click here to login.
External Resources

MJH Associates
American Journal of Managed Care
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
OncNurse Resources

Continuing Education
Web Exclusives

About Us
Advisory Board
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2018
Intellisphere, LLC. All Rights Reserved.